Literature DB >> 29804849

The impact of unplanned conversion to an open procedure during minimally invasive pancreatectomy.

Zachary E Stiles1, Paxton V Dickson1, Jeremiah L Deneve1, Evan S Glazer1, Lei Dong1, Jim Y Wan2, Stephen W Behrman3.   

Abstract

BACKGROUND: Minimally invasive pancreatic resection (MIPR) is being increasingly utilized. Outcomes for patients experiencing unplanned conversion to an open procedure during MIPR have been incompletely assessed. We sought to determine the short-term outcomes and factors associated with unplanned conversion during MIPR.
METHODS: A retrospective cohort study using the American College of Surgeons National Surgical Quality Improvement Program pancreatectomy-targeted data set was conducted. Successful MIPR was compared with unplanned conversion. Propensity matching was used to separately compare unplanned conversion during MIPR with planned open pancreatectomy.
RESULTS: Unplanned conversion occurred in 24.6% of 350 attempted minimally invasive pancreatoduodenectomy (MIPD) and 19.6% of 1174 attempted minimally invasive distal pancreatectomy (MIDP). Conversion was associated with greater overall morbidity and 30-day mortality compared with successful MIPR for both MIPD and MIDP. After matching, unplanned conversion resulted in outcomes equivalent or inferior to open pancreatectomy. Factors significantly associated with unplanned conversion during MIPD included intermediate gland texture, vascular resection, hypertension, disseminated cancer, and chronic steroid use. For MIDP, male sex, hard gland texture, vascular resection, smoking, and recent weight loss were independently associated with conversion. A robotic approach was inversely associated with conversion for MIPD and MIDP.
CONCLUSIONS: Unplanned conversion during MIPR is associated with greater morbidity and 30-day mortality. Conversion resulted in outcomes that, at best, mimicked those of open pancreatectomy. Several risk factors including the need for vascular resection are associated with unplanned conversion and should be acknowledged when planning an operative approach.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Minimally invasive; NSQIP; Outcomes; Pancreas; Pancreatectomy

Mesh:

Year:  2018        PMID: 29804849     DOI: 10.1016/j.jss.2018.02.028

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  International consensus statement on robotic pancreatic surgery.

Authors:  Rong Liu; Go Wakabayashi; Chinnusamy Palanivelu; Allan Tsung; Kehu Yang; Brian K P Goh; Charing Ching-Ning Chong; Chang Moo Kang; Chenghong Peng; Eli Kakiashvili; Ho-Seong Han; Hong-Jin Kim; Jin He; Jae Hoon Lee; Kyoichi Takaori; Marco Vito Marino; Shen-Nien Wang; Tiankang Guo; Thilo Hackert; Ting-Shuo Huang; Yiengpruksawan Anusak; Yuman Fong; Yuichi Nagakawa; Yi-Ming Shyr; Yao-Ming Wu; Yupei Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

2.  Predictors and outcomes of converted minimally invasive pancreaticoduodenectomy: a propensity score matched analysis.

Authors:  Caitlin A Hester; Ibrahim Nassour; Alana Christie; Mathew M Augustine; John C Mansour; Patricio M Polanco; Matthew R Porembka; Thomas H Shoultz; Sam C Wang; Adam C Yopp; Herbert J Zeh; Rebecca M Minter
Journal:  Surg Endosc       Date:  2019-04-23       Impact factor: 4.584

3.  Resection or repair of large peripancreatic arteries during robotic pancreatectomy.

Authors:  Emanuele F Kauffmann; Niccolò Napoli; Concetta Cacace; Francesca Menonna; Fabio Vistoli; Gabriella Amorese; Ugo Boggi
Journal:  Updates Surg       Date:  2020-02-18

4.  Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy?

Authors:  Mengyu Feng; Zhe Cao; Zhiwei Sun; Taiping Zhang; Yupei Zhao
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

5.  500 Minimally Invasive Robotic Pancreatoduodenectomies: One Decade of Optimizing Performance.

Authors:  Amer H Zureikat; Joal D Beane; Mazen S Zenati; Amr I Al Abbas; Brian A Boone; A James Moser; David L Bartlett; Melissa E Hogg; Herbert J Zeh
Journal:  Ann Surg       Date:  2021-05-01       Impact factor: 13.787

6.  Converted laparoscopic distal pancreatectomy: is there an impact on patient outcome and total cost?

Authors:  Riccardo Casadei; Carlo Ingaldi; Claudio Ricci; Emilio De Raffele; Laura Alberici; Francesco Minni
Journal:  Langenbecks Arch Surg       Date:  2022-02-07       Impact factor: 2.895

7.  Risk factors and consequences of conversion in minimally invasive distal pancreatectomy.

Authors:  Zhiyu Jiang; Long Pan; Mingyu Chen; Bin Zhang; Juengpanich Sarun; Sandra Fan; Xiujun Cai
Journal:  J Minim Access Surg       Date:  2022 Jul-Sep       Impact factor: 1.018

8.  Protocol for a randomised controlled trial to compare postoperative complications between minimally invasive and open DIStal PAnCreaTectomy (DISPACT-2 trial).

Authors:  Pascal Probst; Fabian Schuh; Colette Dörr-Harim; Anja Sander; Thomas Bruckner; Christina Klose; Inga Rossion; Felix Nickel; Beat Peter Müller-Stich; Arianeb Mehrabi; Thilo Hackert; Markus W Büchler; Markus K Diener
Journal:  BMJ Open       Date:  2021-02-22       Impact factor: 2.692

Review 9.  Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?

Authors:  Chang Moo Kang; Woo Jung Lee
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.